A class action lawsuit has been filed against Alcoa, over emissions from its three alumina refineries in the western Australia. The legal action against Alcoa, will take place in United States. The lawsuit will be spearheaded by the environmental campaigner Erin Brockovich.
Italy’s dairy group Parmalat SpA said that it will issue new stock valued at more than $36 million to settle a class-action case against it. Parmalat will also pay up to 1 million euros ($1.55 million) of the cost of notifying the class members of the settlement, the statement said.
At a decision at the Missouri Court of Appeals, the court has decided to rewrite part of a proposed constitutional amendment banning a particular type of embryonic stem cell research. However, the sponsoring group, Cures Without Cloning, would have to turn in about 150,000 signatures by Sunday.
Whirlpool, is going to settle its, class action lawsuit over the defective water heater issue. The company sources told that the affected consumers are given two months time to file claims in the settlement. Nearly 1000 consumers have filed complaints that thermocouple in their Flame Lock or Flame Guard Whirlpool water heaters continuously breaks down, leaving them without hot water sometimes for days. They have filed their complaints with consumeraffairs.com.
It can be mentioned that the water heaters sold at Lowe’s were found to be defective. The thermocouple which is the safety device of water heater was found defective. If the pilot light goes out, Thermocouple, cuts off the flow of gas, thereby preventing gas from leaking out.
Brodsky & Smith, LLC announces that a class action lawsuit has been filed on behalf of all the purchasers of the common stock of The Blackstone Group L.P. The class action lawsuit was filed in the United States District Court for the Southern District of New York.
Kuslima Shogun, CEO and founder of biopharmaceutical giant Alfcell, plans to retire by the March 31 of next year. The retirement came as a part of a deal the company said could reduce royalty payments to Shogun by $20 million over the next 10 years if the company’s lead drug candidate, Onconase, is approved by the Food and Drug Administration. Additionally, Onconase is a proposed treatment for malignant mesothelioma.